title: Point: cervical cancer screening guidelines should consider observational data on screening efficacy in older women.
abstract: Recent guidelines from the American Cancer Society, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology recommend cessation of cervical cancer screening at age 65 years for women with an "adequate" history of negative Papanicolaou smears. In our view, those who formulated these guidelines did not consider a growing body of evidence from nonrandomized studies that provides insight into the efficacy of cervical cancer screening among older women. First, older women are not at indefinitely low risk following negative screening results. Second, recent data from the United States, the United Kingdom, and Sweden suggest that screening of older women is associated with substantial reductions in cervical cancer incidence and mortality, even among previously screened women. It may be that after consideration of the reduced incidence of (and reduced mortality from) cervical cancer that may result from screening older women, the harms and economic costs of screening will be judged to outweigh its benefits. However, it is essential to consider the now-documented benefits of cervical screening when formulating screening guidelines for older women, and recommendations that do not do so will lack an evidence base.
authors: Alison S
authors: AS
authors: Rustagi
authors: Aruna
authors: A
authors: Kamineni
authors: Noel S
authors: NS
authors: Weiss
mesh_terms: D000367:Age Factors; D000368:Aged; D055088:Early Detection of Cancer / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D065006:Papanicolaou Test / Q000706:statistics & numerical data; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000453:epidemiology
keywords: Papanicolaou smear; cervical cancer; health policy; screening; women's health
references: J Natl Cancer Inst. 2008 May 7;100(9):622-9
references: 18445828
references: BMJ. 2009 Apr 24;338:b1354
references: 19395420
references: Br J Cancer. 1991 Sep;64(3):559-65
references: 1911199
references: Int J Cancer. 2006 Dec 1;119(11):2677-84
references: 16991121
references: CA Cancer J Clin. 2012 May-Jun;62(3):147-72
references: 22422631
references: Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3044-54
references: 20952561
references: BMJ. 2009 Jul 28;339:b2968
references: 19638651
references: J Adolesc Health. 2008 Oct;43(4 Suppl):S5-25, S25.e1-41
references: 18809145
references: Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1398-409
references: 21602310
references: BJOG. 2004 Apr;111(4):362-8
references: 15008774
references: Obstet Gynecol. 2000 Aug;96(2):219-23
references: 10908766
references: BMJ. 2012 Mar 01;344:e900
references: 22381677
references: Br J Cancer. 1996 Sep;74(5):814-9
references: 8795587
references: IARC Sci Publ. 1986;(76):15-24
references: 3570401
references: Lancet Oncol. 2008 May;9(5):425-34
references: 18407790
references: Bull Cancer. 2012 Apr 1;99(4):409-15
references: 22450525
references: Br J Cancer. 2003 Jul 7;89(1):88-93
references: 12838306